ライフサイエンスコーパス: TOF

1 TOF is associated with various types of right ventricula

2 TOF LCMS analyses identified two phenolic acids as the m

3 with excellent productivity (TON up to 1422; TOF up to 23.3 h(-1)) under mild conditions (25 degrees

4 ed by the laser ablation setup, an icpTOF 2R TOF-based ICP-MS instrument was used for analysis, which

5 , which are finally analyzed by LC-HRMS on a TOF mass spectrometer.

6 ncing secondary ion signals acquired using a TOF detector incorporated into a commercial Ga(+) FIB-SE

7 erformance for the OER at neutral pH, with a TOF value (0.034 s(-1) at an overpotential of 400 mV) an

8 With an accurate TOF-based (timing offsets and timing resolutions) calibr

9 ates exhibit a higher specific SCR activity (TOF).

10 sures of PR and RV volumes in patients after TOF repair with concomitant haemodynamic abnormalities.

11 WCNT electrocatalysts achieve TON > 5600 and TOF > 1.6 s(-1).

12 Baseline non-TOF and TOF PET images were reconstructed.

13 In 40 and 50 of these cases (non-TOF and TOF, respectively), the detectability of the lesions did

14 ny breakthroughs in recent years, the CI-APi-TOF has many limitations, preventing for instance the un

15 ace time-of-flight mass spectrometry (CI-APi-TOF) for monitoring these compounds.

16 ace time-of-flight mass spectrometry (CI-APi-TOF) using two different chemical ionization methods, i.

17 ar sensitivity and selectivity as the CI-APi-TOF, but with over an order of magnitude higher mass res

18 rganofluorine combustion-ion chromatography (TOF-CIC) revealed that fluorotelomer betaines were a sub

19 ed on chemical ionization-time-of-flight (CI-TOF) mass spectrometry employing the "Vocus" ion source

20 In our cohort, TOF was significantly associated with a genotyped single

21 This gives a new opportunity for combining TOF-SIMS analysis with other instruments within the same

22 l composition in cases where the more common TOF applications would not have been able to distinguish

23 aluated 184 consecutive previously diagnosed TOF patients who underwent CT angiography in our departm

24 lity and repeatability of the developed EESI-TOF-MS were tested under complex dynamic and periodic ex

25 d further, it enabled the acquisition of ESI TOF and ESI single quadrupole mass spectrometry instrume

26 ion-time-of-flight mass spectrometry (CE-ESI-TOF-MS) has been developed.

27 es; MS of certain clusters, for example, ESI-TOF of Au(40)(SR)(24), is not successful at all.

28 d extraction (UAE) and the platform HPLC-ESI-TOF-MS was employed to characterize these components in

29 s were identified and quantified by HPLC-ESI-TOF-MS.

30 the basis of the additional dimension of ESI-TOF-MS.

31 IR spectroscopy, and mass spectrometry (ESI-TOF and LC-MS), as well as (17)O solid state NMR (for th

32 ion to NOTCH1, FLT4 and the well-established TOF gene, TBX1, we identified potential association with

33 EUV TOF results agree well with those obtained on the same e

34 EUV TOF's ability to assess and map isotopic heterogeneity a

35 zation time-of-flight mass spectrometry (EUV TOF) to map uranium isotopic heterogeneity at the nanosc

36 ically distinct feedstocks, we show that EUV TOF can map the (235)U/(238)U content in 100 nm-sized pi

37 Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart diseas

38 g adults with corrected tetralogy of Fallot (TOF) or pulmonary stenosis (PS) referred for pulmonary v

39 mic abnormalities after tetralogy of Fallot (TOF) repair, who had undergone cardiovascular magnetic r

40 % (n=326) of these have tetralogy of Fallot (TOF), comprising the largest subset of severe congenital

41 he local gas pressure at the location of FIB-TOF-SIMS analysis.

42 tion/ionization (SELDI) with time-of flight (TOF) proteomics to identify low molecular weight protein

43 constructed with and without time of flight (TOF) to assess quantification accuracy and uniformity.

44 pes of mass analyzers, i.e., time-of-flight (TOF) and Fourier transform ion cyclotron resonance (FTIC

45 vailable data sets from both time-of-flight (TOF) and Orbitrap instruments and demonstrate up to 88%

46 ly chirped laser pulses in a time-of-flight (TOF) mass spectrometry setup.

47 ation (MALDI) coupled with a time-of-flight (TOF) mass-spectrometry (MS) detector is acknowledged to

48 r mass misalignment in axial time-of-flight (TOF) MSI continues to be a serious issue.

49 By time-of-flight (TOF) neutron diffraction experiments, the influence of s

50 sing applications, where the time-of-flight (TOF) of photons is used to recover distance information.

51 Time-of-flight (TOF) PET data provide an effective means for attenuation

52 raphy (PET) in an integrated time-of-flight (TOF) PET/magnetic resonance (MR) imaging system.

53 ucose (FDG) and simultaneous time-of-flight (TOF) PET/MRI with hippocampal subfield analysis of AD, m

54 mensions: optical phase, and time-of-flight (TOF), the latter with 22 picosecond resolution.

55 equency measurement) and via time-of-flight (TOF; time measurement).

56 fied limits and the brain concentrations for TOF MS (51.1 +/- 4.4 pmol/mg) and FTICR MS (56.9 +/- 6.0

57 Results For TOF and non-TOF, respectively, the phantom study reveale

58 A thorium-organic framework (TOF-16) containing hexameric secondary building units co

59 hieving record maximum turnover frequencies (TOF(max)) on the order of 16 000 s(-1).

60 The turnover frequencies (TOF) of these Lewis pair catalyzed processes were as hig

61 (TON, up to 6700) and turnover frequencies (TOF).

62 Turnover frequencies (TOFs) from chemical reduction (66 vs 6 h(-1)) and rate c

63 c substrates with high turnover frequencies (TOFs) up to 560 s(-1) and those that oxidize metal ions

64 ll NO conversion with a turn-over-frequency (TOF) of around 330 h(-1) per Rh atom at 120 degrees C.

65 show trade-offs between turnover frequency (TOF) and the effective overpotential required to initiat

66 The determined turnover frequency (TOF) for each active site of PtSn(4) is 1.54 H(2) s(-1)

67 le redox mediator with a turnover frequency (TOF) of 11+/-1 s(-1) .

68 icles with a record-high turnover frequency (TOF) of 24.3 e(-) site(-1) s(-1) at 0.85 V vs. RHE) and

69 ne (H3 NBH3 , AB) with a turnover frequency (TOF) of 4896.8 h(-1) and an activation energy (Ea ) of 1

70 29 % yield in 9 h with a turnover frequency (TOF) of approximately 14 h(-1) .

71 urnover number (TON) and turnover frequency (TOF) registering up to 2 x 10(3) and 165 h(-1) at rt, re

72 t a ~13-fold increase in turnover frequency (TOF) under typical extreme HB conditions (200 atm reacta

73 ibits an extremely large turnover frequency (TOF) up to 12500 h(-1) at -0.95 V versus the reversible

74 ography time-of-flight mass spectrometry (GC-TOF MS) and liquid chromatography Orbitrap mass spectrom

75 ography time-of-flight mass spectrometry (GC-TOF MS) and liquid chromatography Orbitrap mass spectrom

76 ADAP-GC 4.0 has been evaluated using GC-TOF data sets from a 27-standards mixture at different d

77 entified a total of 327 metabolites using GC-TOF MS and LC-Orbitrap MS.

78 semi-quantified in maternal plasma using GC-TOF MS and LC-Orbitrap-MS.

79 th time-of-flight mass spectrometry (GC x GC-TOF-MS) was combined with conventional mono-dimensional

80 A GCxGC-TOF/MS method was set up for the multiresidue analysis o

81 c oxidases has been elucidated, and the high TOF is achieved through rapid intramolecular electron tr

82 However, TOF-SIMS images of 50 nm or smaller objects do not neces

83 nging AC problem for brain studies in hybrid TOF PET/MR scanners.

84 LA-ICP-TOF-MS is employed to detect naturally occurring isotope

85 sma time-of-flight mass spectrometry (LA-ICP-TOF-MS).

86 plasma time-of-flight mass spectrometry (ICP-TOF-MS).

87 quadrupole-ion mobility-time-of-flight (Q-IM-TOF) mass spectrometer in particular, by exploiting the

88 ange enhancement (DRE) lens of a Waters Q-IM-TOF, or the exit lens of a transfer multipole of a Therm

89 time-of-flight mass spectrometry (LAESI-IMS-TOF-MS) was used for the analysis of synthetic polymers

90 nd 500 degrees C) and a ~43-fold increase in TOF under ideal HB conditions (20 atm reactant pressure

91 A sensitive and straightforward LC-IT-TOF-MS method was validated for the profiling and simult

92 We analysed by LCMS-IT-TOF the composition and content of isoflavonoids, produc

93 t we confirmed using high-resolution LCMS-IT-TOF.

94 d and accurate method, by using the LC-MS-IT-TOF technology, to detect and quantify CBD, CBDV, Delta(

95 t method in PET/MR, regional errors of joint TOF PET reconstructions are within a few percentage poin

96 /+) degradation series in the respective LDI-TOF MS studies.

97 , we uncover the factors that govern the low TOF in Fet3p, a prototypical metallooxidase, in the cont

98 ) and those that oxidize metal ions with low TOFs, ~1 s(-1) or less.

99 MALDI TOF-TOF analysis suggested covalent (ester bond) and non

100 The method was developed using a MALDI TOF instrument in negative ion mode, equipped with a hig

101 ssays, LC-MS-based quantification, and MALDI TOF-TOF MS analyses, we found that MaMmp10 catalyzes the

102 n of CD11b/CD18 function, we performed MALDI TOF Mass Spectrometry (MS) analyses on CD11b/CD18 purifi

103 MALDI-TOF enzymatic fingerprinting and NMR experiments reveale

104 MALDI-TOF mass spectrometry analyses revealed the oxidation of

105 MALDI-TOF MS data combined with multivariate analysis, such as

106 MALDI-TOF MS has shown great utility for rapidly identifying m

107 MALDI-TOF MS is becoming more commonplace for the genus- and/o

108 MALDI-TOF MS significantly improved TAT for organism ID.

109 MALDI-TOF MS-based structural analysis of the mutant CWPS comb

110 MALDI-TOF profiles demonstrated that Burkholderia lipid A cont

111 In a MALDI-TOF DUB assay, we quantitate the amount of mono-ubiquiti

112 7 cerebrosides in a single run using a MALDI-TOF instrument.

113 fragment was detected at m/z 1088 by a MALDI-TOF mass spectrometry.

114 Therefore, here we propose a MALDI-TOF-MS method for identification and relative quantifica

115 we have evaluated by HPLC-DAD, DLS and MALDI-TOF a synergic effect of the coexistence of two salivary

116 grees C using a spectrophotometer) and MALDI-TOF MS (both the standard result output and by visual sp

117 edominant clone identified by MLST and MALDI-TOF, and CR-KP infection was associated with increased h

118 dies it was identified by SDS-PAGE and MALDI-TOF-MS that ZnPP formation takes place in myoglobin.

119 characterized by SDS-page, RP-HPLC and MALDI-TOF-MS.

120 s also characterized by FTIR, NMR, and MALDI-TOF.

121 <15 kDa) as determined by SDS-PAGE and MALDI-TOF/MS analyses.

122 id), and analysed in a Bruker Biotyper MALDI-TOF.

123 ht Mass spectrometry) using the Bruker MALDI-TOF Biotyper system (Bruker Daltonik, Bremen, Germany).

124 ntification of Mycobacteria species by MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of

125 in a bottom-up proteomics approach by MALDI-TOF mass spectrometry (MS).

126 fermented bovine milk were analysed by MALDI-TOF mass spectrometry, and their tryptic digestion produ

127 dilution of milks in water followed by MALDI-TOF MS analyses in the positive linear ion mode and usin

128 trometry (MS) types were identified by MALDI-TOF MS analysis, 53.5% isolates were MS4 and MS6, which

129 SDS-PAGE and protein identification by MALDI-TOF MS.

130 ted from the capillary and analyzed by MALDI-TOF MS.

131 o Spanish hospitals, identification by MALDI-TOF was only attempted on presumptive non-tuberculosis m

132 Results given by MALDI-TOF were compared with the reference methods used for id

133 Bacteria were identified by MALDI-TOF, antimicrobial susceptibility testing followed EUCAS

134 nd E nterobacter spp. were analyzed by MALDI-TOF-MS in negative ion mode to obtain glycolipid mass sp

135 e isolated, and structural analysis by MALDI-TOF-MS, GC-MS, and 2D NMR revealed that both were atypic

136 ully identified directly from broth by MALDI-TOF.

137 blotting-protocol then investigated by MALDI-TOF/MS.

138 cumventing the need for a pure colony, MALDI-TOF mass spectrometry of bacterial membrane glycolipids

139 nd complementary approach by comparing MALDI-TOF mass spectra of microbial membrane lipid fingerprint

140 culturing can be avoided by conducting MALDI-TOF MS on individual bacterial cells.

141 targets and may be used for different MALDI-TOF MS applications.

142 from kinetic investigations and DSC-, MALDI-TOF-MS-, (1)H NMR-studies of linear polymers prepared in

143 provement in specificity over existing MALDI-TOF-based bacterial identification platforms for the ide

144 desorption ionization-time of flight (MALDI-TOF) analyses following trypsin digestion of the three v

145 desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry applications in dual polarity mol

146 desorption ionization time-of-flight (MALDI-TOF) mass spectrometry showed that DIM molecules are tra

147 desorption ionization-time of flight (MALDI-TOF) mass spectrometry.

148 desorption/ionization time of flight (MALDI-TOF) mass spectrometry.

149 desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.

150 desorption/ionization-time of flight (MALDI-TOF) mass spectrometry.

151 desorption/ionization time-of-flight (MALDI-TOF) MS analysis of microbial proteins.

152 desorption ionization-time of flight (MALDI-TOF) MS organism identification and automated-system-bas

153 Desorption/Ionization Time-of-Flight (MALDI-TOF) technique for bacterial identification after cultur

154 e subcultured on blood agar plates for MALDI-TOF analysis.

155 could be inactivated and extracted for MALDI-TOF analysis.

156 successfully applied as the matrix for MALDI-TOF mass spectrometry imaging (MSI) for studying the mou

157 ieve a trustworthy identification from MALDI-TOF MS data, a significant amount of biomass should be c

158 e containers and obtained identifiable MALDI-TOF MS collagen fingerprints, all indicative of the same

159 e the additional costs of implementing MALDI-TOF and of dedicating pharmacy stewardship personnel tim

160 p-regulated in 5-FU-resistant cells in MALDI-TOF analysis.

161 With increasing MALDI-TOF MS use, CLs are well-advised to adhere strictly to s

162 Moreover, MALDI-TOF MSI results were obtained for lipid distributions, m

163 mbined with highly sensitive LC-MS/MS, MALDI-TOF-MS, and exoglycosidase treatments.

164 red, demonstrate the value of this new MALDI-TOF MS method as an analytical tool for the identificati

165 is study was to evaluate the impact of MALDI-TOF MS alone versus MALDI-TOF MS combined with real-time

166 Use of MALDI-TOF MS and TLA individually and together results in sign

167 aluated the capacity of combination of MALDI-TOF MS and urine analysis (UA) for direct detection and

168 sifier, to bacterial classification of MALDI-TOF MS data.

169 ee sites, while specificity and NPV of MALDI-TOF MS for males were significantly higher than those fo

170 monstrate the promising application of MALDI-TOF MS in evaluating the photodynamic effect of each com

171 Comparison of MALDI-TOF-MS spectra of all obtained extracts clearly indicate

172 ither secondary biochemical testing or MALDI-TOF MS is of practical value.

173 In conclusion, performing MALDI-TOF mass spectrometry analyses in oxidizing conditions,

174 adaptation of the previously published MALDI-TOF-based DUB assay method.

175 Recently, MALDI-TOF MS-based methodologies for bacteria detection/identi

176 species were used to create reference MALDI-TOF spectra, which were then used for the identification

177 based on lipids fingerprint by routine MALDI-TOF mass spectrometry (MS).

178 xin test for the MALDI Biotyper Sirius MALDI-TOF MS system (Bruker Daltonics).

179 tion-time-of-flight mass spectrometry (MALDI-TOF MS) after enzymatic digestion of the polysaccharide

180 tion time of flight mass spectrometry (MALDI-TOF MS) analysis allowing in minutes the identification

181 tion-time of flight mass spectrometry (MALDI-TOF MS) and automated identification systems as well as

182 tion-time of flight mass spectrometry (MALDI-TOF MS) and evaluated the capacity of combination of MAL

183 tion-time-of-flight mass spectrometry (MALDI-TOF MS) can be applied for the identification of pathoge

184 tion-time of flight mass spectrometry (MALDI-TOF MS) decreases the time to organism identification an

185 tion-time of flight mass spectrometry (MALDI-TOF MS) for yeast isolate identification, real-time PCR

186 tion-time of flight mass spectrometry (MALDI-TOF MS) identification and broth microdilution phenotypi

187 tion-time of flight mass spectrometry (MALDI-TOF MS) in less than 15 min but is not optimized for the

188 tion time-of-flight mass spectrometry (MALDI-TOF MS) is described in this study.

189 tion-time of flight mass spectrometry (MALDI-TOF MS) or gene sequencing.

190 tion time-of-flight mass spectrometry (MALDI-TOF MS) plates, termed fast lipid analysis technique or

191 tion-time of flight mass spectrometry (MALDI-TOF MS) system was able to identify S. delphini to the s

192 tion time-of-flight mass spectrometry (MALDI-TOF MS) target plates printed by FDM technology using co

193 sorption/ionization mass spectrometry (MALDI-TOF MS) that allows quantification of pure or mixed dete

194 tion time of flight mass spectrometry (MALDI-TOF MS) with only 1 muL of sample in a fast (less than 1

195 tion-time of flight mass spectrometry (MALDI-TOF MS), and 16S rRNA partial genome sequence analysis w

196 tion-time of flight mass spectrometry (MALDI-TOF MS), gas chromatography (GC), SDS-PAGE, Toll-like re

197 tion-time of flight mass spectrometry (MALDI-TOF MS), which has a limited capacity to identify biolog

198 tion Time-of-Flight Mass Spectrometry (MALDI-TOF MS).

199 tion time-of-flight mass spectrometry (MALDI-TOF MS).

200 tion-time of flight mass spectrometry (MALDI-TOF MS).

201 tion time-of-flight mass spectrometry (MALDI-TOF MS).

202 tion-time of flight mass spectrometry (MALDI-TOF) in Central China.

203 ered approach using mass spectrometry (MALDI-TOF), microscopy (SEM, Raman), and microbiological techn

204 tion time-of-flight mass spectrometry (MALDI-TOF-MS) analysis of high abundance proteins is gaining p

205 tion time-of-flight mass spectrometry (MALDI-TOF-MS) is the preferred instrumental platform for finge

206 tion time-of-flight mass spectrometry (MALDI-TOF-MS).

207 ne-6-ethyl moiety by NMR spectroscopy, MALDI-TOF mass spectroscopy, UV-Vis spectroscopy, and titratio

208 ence by database search and subsequent MALDI-TOF/TOF analysis.

209 ere identified by biochemical testing, MALDI-TOF MS, and 16S rRNA sequence analysis (179 isolates; 2

210 Here, we demonstrate that MALDI-TOF mass spectrometry accurately identified all of the t

211 Results suggest that MALDI-TOF MS and multivariate analysis are useful in determini

212 to the species level, suggesting that MALDI-TOF MS is the best option for distinguishing members of

213 technologies currently available, the MALDI-TOF DUB assay combines the use of physiological substrat

214 he beads are directly dispensed on the MALDI-TOF MS target enabling the identification and sensitive

215 ociated polysaccharides (CWPS) through MALDI-TOF MS and methylation analysis, we report on three such

216 stent with bactericidal rates and thus MALDI-TOF MS might be able to replace the LB agar colony to ev

217 AMS intervention included: real-time MALDI-TOF MS pharmacist notification and prospective AMS provi

218 learning techniques can be applied to MALDI-TOF mass spectral data of drug-treated cells to obtain c

219 d in a plastic bag, provided no useful MALDI-TOF MS spectra.

220 d crystals in their solid state, using MALDI-TOF and Raman spectroscopy.

221 rowing organisms in BSCs and not using MALDI-TOF MS for identification until BTAs have been ruled out

222 he impact of MALDI-TOF MS alone versus MALDI-TOF MS combined with real-time, pharmacist-driven, antim

223 positive blood cultures identified via MALDI-TOF MS combined with prospective AMS intervention compar

224 fication, that is, NMR, FT-IR, UV-vis, MALDI-TOF spectral data, single crystal X-ray diffraction, and

225 gainst all Exophiala isolates in vitro MALDI-TOF MS successfully distinguished all 18 species and ide

226 d with RP HPLC, and characterized with MALDI-TOF MS and enzyme digestion essays.

227 hemical treatments in combination with MALDI-TOF MS and MS/MS.

228 WGS showed 99 and 93% concordance with MALDI-TOF MS at the genus and species levels, respectively.

229 tion compared to a control cohort with MALDI-TOF MS identification without AMS intervention.

230 xed ion beam imaging by time of flight (MIBI-TOF), we uncovered the spatial organization of metabolic

231 ELIT, multiple reflection-time-of-flight (MR-TOF) mass spectra are shown to demonstrate separation in

232 s occur with residence times as low as 6 ms (TOF = 24 000 000 h(-1)) and can be readily scaled-up to

233 were successfully identified by HPLC-DAD-MS-TOF and HPLC-FLD analysis.

234 Eight hundred twenty-nine TOF patients underwent whole exome sequencing.

235 ses, the detectability changed; and in 2 non-TOF cases, the lesions were no longer visible after the

236 We have presented a non-TOF emission-based approach for estimating the attenuati

237 Results For TOF and non-TOF, respectively, the phantom study revealed a mean PET

238 Baseline non-TOF and TOF PET images were reconstructed.

239 In 40 and 50 of these cases (non-TOF and TOF, respectively), the detectability of the les

240 riants in the largest cohort of nonsyndromic TOF patients reported to date.

241 enetic variants predisposing to nonsyndromic TOF, followed by FLT4.

242 nts in these genes are found in almost 7% of TOF patients.

243 ts were found in 2.4% (95% CI, 1.6%-3.8%) of TOF patients, with 21 patients harboring 22 unique, dele

244 Our studies prove the capability of TOF-SIMS to image chemical structure of nanohybrids whic

245 allowed us to demonstrate the capability of TOF-SIMS to spatially resolve individual tens of nanomet

246 The provided comparison of TOF-SIMS and STEM/EDX characteristics delivers guideline

247 The dependence of TOF on etaeff is shown to be quite different upon changi

248 an important role in the future evolution of TOF-SIMS analytical protocols, as currently the mass int

249 The inclusion of TOF information significantly reduced artifacts due to s

250 gamma-irradiation of TOF-16 to an unprecedented 4 MGy dose resulted in no app

251 art disease, but relatively small numbers of TOF cases have been studied to date.

252 We report the first use of TOF-SIMS MS/MS imaging for the cellular localization and

253 In particular, TOF-SIMS and confirmatory MALDI FT-ICR MS (/MS) analysis

254 ncrease in pressure compared to standard PTR-TOF-MS.

255 ull scan methods using high resolution GC-(q)TOF and GC-Orbitrap systems.

256 d for analysis of cytochrome c, on a DTIMS Q-TOF similar rates were obtained, and on a TWIMS Q-TOF ut

257 HPLC-ESI-Q-TOF allowed the detection of 25 different raw formulas m

258 This study presents an HPLC-ESI-Q-TOF method for simultaneous quantification of short-chai

259 was done by UPLC(R)-QqQ-MS and UPLC(R)-ESI-Q-TOF-MS(E).

260 ully applied in quadrupole time-of-flight (Q-TOF) instruments.

261 te that a MALDI quadrupole time-of-flight (Q-TOF) mass spectrometer with trapped ion mobility spectro

262 ormones using a quadrupole-time-of-flight (Q-TOF) MS by direct injection and LC-MS/MS.

263 d to high resolution mass spectrometry (GC/Q-TOF MS).

264 ole time-of-flight mass spectrometry (HPLC-Q-TOF MS) with univariate and multivariate statistical ana

265 onsistent with data previously acquired on Q-TOF platforms, matching predictions from known protein i

266 impact on sensitivity on a high-resolution Q-TOF equipped with ETD and an electrospray ionization int

267 AJICAP conjugation was established by SEC-Q-TOF-MS.

268 imilar rates were obtained, and on a TWIMS Q-TOF utilizing IM-MS software rates up to 33 Hz are demon

269 led rhizome was carried out utilizing UPLC-Q-TOF-MS(E), LC-QqQ-MS and GC-MS techniques and evaluated

270 ) a laser system setup coupled to a Waters Q-TOF or Thermo Fisher Q Exactive mass analyzer, (ii) anal

271 ed in Actinidia arguta fruits by LC-MS-PDA-Q/TOF method and in vitro anticholinergic activity.

272 This study aimed to identify by UPLC-PDA-Q/TOF-MS and quantify by UPLC-PDA phenolic compounds (26 f

273 time of flight-mass spectrometry (UPLC-PDA-Q/TOF-MS) method.

274 ng three different approaches: GC/quadrupole-TOF, LC/quadrupole-TOF, and nuclear magnetic resonance (

275 approaches: GC/quadrupole-TOF, LC/quadrupole-TOF, and nuclear magnetic resonance (NMR).

276 trate that combining high spatial resolution TOF-SIMS imaging and MS/MS structural characterization o

277 alkaline solution (E(onset) =0.92 V vs. RHE, TOF=0.25 e(-) site(-1) s(-1) at 0.80 V vs. RHE).

278 he Si-doped Fe catalyst can achieve the same TOF of pure Fe at 200 atm/500 degrees C under much milde

279 ross nine different MS instruments (1 single TOF, 1 Q/orbital ion trap, and 7 QTOF instruments).

280 resolution time-of-flight mass spectrometer (TOF-MS).

281 ionization time-of-flight mass spectrometry (TOF-MS) allows the detection of thousands of compounds.

282 e-of-Flight Secondary Ion Mass Spectrometry (TOF-SIMS) analysis can significantly increase element io

283 e-of-flight secondary ion mass spectrometry (TOF-SIMS) and scanning transmission electron microscopy

284 e-of-flight secondary ion mass spectrometry (TOF-SIMS) detectors have been intensively developed in r

285 e-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging and X-ray photoelectric spectroscopy (

286 e-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging.

287 e-of-flight secondary ion mass spectrometry (TOF-SIMS) is a challenging task.

288 e-of-flight secondary ion mass spectrometry (TOF-SIMS) technique to determine the height topography a

289 e-of-flight-secondary ion mass spectroscopy (TOF-SIMS).

290 old lowers etaeff by 59 mV and decreases the TOF by a factor of 10.

291 For each sample, the difference in the TOF of the same secondary ion coming from two different

292 Methods: The TOF PET emission data were initially used in a preproces

293 onclusion, common variants may contribute to TOF in 22q11.2DS and may function in cardiac outflow tra

294 predominant polyphenols detected with Triple-TOF-LC-MS/MS.

295 l oxidant was used (Ce(IV) , 7400 turnovers, TOF 0.88 s(-1) ).

296 solution of ~400 nm was later achieved using TOF-SIMS MS/MS imaging analysis.

297 sis of various abnormalities associated with TOF.

298 l Canadian cohort enrolled 542 patients with TOF or PS and mild to severe TR who underwent isolated P

299 In patients with TOF or PS and significant TR, concomitant TVI is safe an

300 Of the 575 patients with TOF, 57% were male, and the mean (SD) age was 31 (11) ye

301 coil that was greater with, versus without, TOF reconstruction.